SOFRITTI, Olga
 Distribuzione geografica
Continente #
NA - Nord America 2.101
EU - Europa 644
AS - Asia 523
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.271
Nazione #
US - Stati Uniti d'America 2.092
CN - Cina 282
DE - Germania 154
SG - Singapore 125
UA - Ucraina 121
IT - Italia 109
TR - Turchia 99
GB - Regno Unito 77
FI - Finlandia 51
SE - Svezia 43
FR - Francia 23
CZ - Repubblica Ceca 17
BE - Belgio 16
RU - Federazione Russa 14
PL - Polonia 10
CA - Canada 9
ID - Indonesia 4
IE - Irlanda 3
IR - Iran 3
NL - Olanda 3
AU - Australia 2
IN - India 2
KR - Corea 2
LT - Lituania 2
EU - Europa 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
MY - Malesia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 3.271
Città #
Woodbridge 254
Fairfield 200
Houston 189
Chandler 168
Ann Arbor 166
Jacksonville 143
Santa Clara 126
Singapore 112
Beijing 100
Seattle 88
Ashburn 84
Wilmington 84
Cambridge 70
Izmir 53
New York 51
Nanjing 48
Shanghai 35
Princeton 33
Ferrara 31
Addison 27
Milan 27
San Diego 26
Boardman 23
Helsinki 21
Bremen 19
Nanchang 17
Brno 16
Brussels 16
Los Angeles 14
Shenyang 14
Munich 12
Augusta 10
Warsaw 10
Frankfurt am Main 9
Changsha 8
Jinan 8
San Jose 8
Falls Church 7
Jiaxing 7
London 7
Hebei 5
Leawood 5
Mountain View 5
San Mateo 5
Tianjin 5
Dearborn 4
Hangzhou 4
Hefei 4
Jakarta 4
Norwalk 4
Ottawa 4
Toronto 4
Des Moines 3
Dublin 3
Illasi 3
Redwood City 3
Zhengzhou 3
Ardabil 2
Auburn Hills 2
Bologna 2
Chengdu 2
Guangzhou 2
Orange 2
Taiyuan 2
Verona 2
Calgary 1
Central 1
Changchun 1
Dong Ket 1
Falkenstein 1
Haikou 1
Hounslow 1
Johor Bahru 1
Kunming 1
Lanzhou 1
Melbourne 1
Miami 1
Monmouth Junction 1
Mumbai 1
Ningbo 1
Olomouc 1
Perth 1
Pescara 1
Philadelphia 1
Qingdao 1
Redmond 1
Seoul 1
Simi Valley 1
Stockholm 1
Taizhou 1
Tappahannock 1
Tel Aviv 1
Torino 1
Velp 1
Venezia 1
Washington 1
Wuhan 1
Yellow Springs 1
Šiauliai 1
Totale 2.459
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 166
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 146
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 139
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 137
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 137
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 133
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 128
null 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 124
Delirium in acute promyelocytic leukemia patients: two case reports. 121
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 119
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 113
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 112
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 111
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 104
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 101
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 101
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 100
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 91
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 90
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 84
Neoplastic circulating endothelial cells in hematologic malignancies 76
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 76
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 74
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 74
Molecular cytogenetic lesions in chronic lymphocytic leukemia 71
null 64
null 59
null 45
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 45
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 36
Neoplastic circulating endothelial cells in hematologic malignancies 28
Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome 27
Neoplastic circulating endothelial cells in hematologic malignancies. 24
Totale 3.318
Categoria #
all - tutte 15.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 0 0 0 0 0 65 54 50 46 78 30 10
2020/2021484 32 23 15 58 19 52 25 44 8 47 116 45
2021/2022370 39 37 23 10 19 16 15 19 9 30 35 118
2022/2023381 39 31 17 47 70 48 26 30 45 0 19 9
2023/2024192 18 23 5 3 5 54 10 13 4 3 0 54
2024/2025359 11 26 59 38 112 113 0 0 0 0 0 0
Totale 3.318